Recursion Pharmaceuticals Ownership | Who Owns Recursion Pharmaceuticals?
Recursion Pharmaceuticals Ownership Summary
Recursion Pharmaceuticals is owned by 74.03% institutional investors, 4.75% insiders, and 21.23% retail investors. Vanguard group is the largest institutional shareholder, holding 12.04% of RXRX shares. ARK Innovation ETF is the top mutual fund, with 4.60% of its assets in Recursion Pharmaceuticals shares.
RXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Recursion Pharmaceuticals | 74.03% | 4.75% | 21.23% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Vanguard group | 34.01M | 12.04% | $229.91M |
| Baillie gifford | 24.86M | 8.80% | $168.08M |
| Ark investment management | 32.99M | 7.90% | $166.92M |
| Blackrock | 17.31M | 7.33% | $129.83M |
| Blackrock funding, inc. /de | 28.37M | 6.80% | $143.56M |
| State street | 8.75M | 3.71% | $65.62M |
| Softbank group | 14.67M | 3.51% | $74.22M |
| Kinnevik ab (publ) | 13.43M | 3.22% | $67.98M |
| Sumitomo mitsui trust | 8.98M | 3.18% | $60.71M |
| Mubadala investment co pjsc | 12.99M | 3.11% | $65.71M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kinnevik ab (publ) | 13.43M | 100.00% | $67.98M |
| Data collective iv gp | 5.94M | 23.14% | $30.06M |
| Dcvc opportunity fund ii gp | 3.95M | 17.35% | $19.99M |
| Mic capital management uk llp | 9.64M | 9.58% | $48.80M |
| Nan fung group | 664.61K | 5.30% | $3.36M |
| Novo | 9.67M | 3.45% | $48.91M |
| Pivotal bioventure partners investment advisor | 595.52K | 1.87% | $3.01M |
| Ark investment management | 32.99M | 1.22% | $166.92M |
| Carroll investors | 385.60K | 1.03% | $1.95M |
| Nvidia | 7.71M | 0.90% | $38.99M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vanguard group | 34.01M | 0.00% | 9.74M |
| Blackrock | 17.31M | 0.00% | 4.99M |
| Blackrock funding, inc. /de | 28.37M | 0.00% | 4.86M |
| Norges bank | 3.47M | 0.00% | 3.47M |
| Ubs group | 3.00M | 0.00% | 2.20M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ra capital management | - | - | -7.73M |
| Deerfield management company, l.p. (series c) | - | - | -2.31M |
| Ark investment management | 32.99M | 1.22% | -1.83M |
| State street | 8.75M | 0.00% | -1.60M |
| Laurion capital management lp | - | - | -1.55M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 3.47M | 0.00% | 3.47M | $23.43M |
| Hrt financial lp | 544.16K | 0.01% | 544.16K | $2.75M |
| Voloridge investment management | 359.43K | 0.01% | 359.43K | $1.82M |
| Sculptor capital lp | 186.00K | 0.01% | 186.00K | $941.16K |
| Capital fund management | 183.80K | 0.00% | 183.80K | $1.24M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Nbc securities | -1.00 |
| Financial gravity asset management | -4.00 |
| Householder group estate & retirement specialist | -11.00 |
| Gradient investments | -15.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 341 | -2.01% | 308,955,617 | 7.04% | 74 | 1.44% | 170 | -16.67% | 85 | 21.43% |
| Mar 31, 2025 | 350 | 4.79% | 304,203,724 | -0.17% | 75 | 0.65% | 204 | 2.51% | 72 | 14.29% |
| Dec 31, 2024 | 308 | 10.79% | 289,638,352 | 11.01% | 102 | 1.20% | 181 | 16.77% | 56 | 12.00% |
| Sep 30, 2024 | 275 | -1.43% | 260,863,978 | 3.59% | 92 | 0.81% | 154 | -13.97% | 49 | - |
| Jun 30, 2024 | 277 | 8.20% | 251,804,695 | 20.07% | 106 | 1.35% | 177 | 12.74% | 49 | -5.77% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Innovation ETF | 19.95M | 4.60% | 1.90M |
| ARK Disruptive Innovation Full Composite | 18.19M | 4.19% | -1.10M |
| Scottish Mortgage Ord | 18.17M | 4.19% | - |
| Vanguard Total Stock Mkt Idx Inv | 12.16M | 2.80% | -259.15K |
| ARK Genomic Revolution | 11.44M | 2.63% | -1.17M |
| ARK Genomic Revolution ETF | 11.33M | 2.61% | -67.93K |
| Vanguard Small Cap Index | 9.22M | 2.12% | -56.27K |
| Vanguard US Total Market Shares ETF | 8.01M | 1.99% | 1.01M |
| iShares Russell 2000 ETF | 8.00M | 1.84% | -152.15K |
| Vanguard Small Cap Growth Index Inv | 5.21M | 1.20% | -1.90K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 26, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $484.00K |
| Aug 18, 2025 | Khan Najat | Chief R&D Commercial Officer | Sell | $202.17K |
| Aug 11, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $2.64M |
| Aug 11, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $94.38K |
| Mar 27, 2025 | Gibson Christopher | Chief Executive Officer | Sell | $836.99K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | 4 |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 7 |
| 2024 Q4 | - | 15 |
| 2024 Q3 | - | 21 |
RXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools